Introduction
In children and young adults, gastric cancer is extremely rare. Lymphoma, sarcoma, and neuroblastoma are the most common childhood cancers [1]. The frequency of gastric adenocarcinomas in children is less than 0.05% [2]. To establish appropriate treatment strategies for gastric carcinoma, it is critical to identify the existence or absence of metastases. Gastric cancer usually spreads to the peritoneal surfaces, distant lymph nodes, and liver, but it can also spread to the spleen, lung, brain, or skin [3]. The prevalence and clinical relevance of bone marrow metastases in paediatric gastric cancer are unknown [4]. Solid tumours in children, such as neuroblastoma, Ewing’s sarcoma, and rhabdomyosarcoma, followed by germ cell tumours and retinoblastoma, are associated with bone marrow metastases in children [5, 6]. The present case study re-emphasises the early utility of bone marrow examination in the management and prognosis of gastric adenocarcinoma in children.
Case report
The paediatric department of King George’s Medical University, Lucknow, a tertiary care medical centre in North India, admitted an 11-year-old child. For 2 months, the patient had lower back aches, followed by loss of bladder and bowel continence, as well as weakness in his lower limbs for 4 weeks. There was a history of weight loss, night sweats, and 2–3 episodes of vomiting per day. The patient denied any history of melena. The patient had an ill-defined lump in the epigastric area that was tender on abdominal examination. A haemoglobin level of 6.9 g/dl, a white blood cell (WBCs) count of 12.0 ´ 103/µl, and a platelet count of 160 ´ 103/µl were observed during the initial laboratory examination. A peripheral blood smear examination showed a leucoerythroblastic blood picture and displayed 100 nucleated red blood cells/100 WBCs (Fig. 1). The results of the renal function and liver function tests (LFT) were within the normal range.
A computerised tomography scan of the thorax, abdomen, and pelvis revealed a fracture of the L1–L3 vertebral body, lytic lesions in the T3–T6 vertebral bodies, and a concentric infiltrative growth in the body and stomach antrum with enlarged lymph nodes in the left upper quadrant of the abdomen. A provisional diagnosis of non-Hodgkin’s lymphoma, germ cell tumour, neuroblastoma, and Ewing sarcoma was made based on clinical and imaging studies.
The patient was hospitalised in a paediatric medical oncology unit for evaluation of disease and management. To access the disease status, a bone marrow aspirate and marrow biopsy were performed from the posterior superior iliac spine under local anaesthesia with strict aseptic conditions. The bone marrow aspiration smears revealed hypocellular haemodiluted smears displaying atypical cells with enlarged eccentric nuclei and a moderate amount of cytoplasm on a blood-mixed mucoid background, indicating tumour metastasis. The number of normal haematopoietic cells was reduced (Fig. 2A, B). Subsequently, the section from the bone marrow biopsy shows evaluable marrow spaces displaying diffuse infiltration by tumour cells disposed in sheets. These tumour cells are signet ring-shaped and have eccentric elongated hyperchromatic nuclei with an abundant amount of cytoplasm (Fig. 2C, D). A battery of immunohistochemical markers was applied to the bone marrow biopsy section, which revealed positive expression of CK7 and CDX2, indicating that the signet ring cells originated in the gastrointestinal tract (Fig. 2E, F). CD20 was negative in tumour cells. Placental-like alkaline phosphatase (PLAP), spalt-like sal-like-4 (SALL-4), leucocyte common antigen, synaptophysin, chromogranin, vimentin, and CD99 staining were negative. As a result, the final diagnosis of metastatic signet ring cell carcinoma of the gastrointestinal origin, most likely upper gastrointestinal tract, was made based on clinical, imaging, morphological, and immunohistochemistry evaluation. A mutation analysis was also performed for the CDH1 gene, which showed negative results.
A workup for a gastrointestinal carcinoma was requested because of the foregoing results. A malignant- appearing growth in the area of the gastric body and pylorus was identified during an endoscopy of the upper gastrointestinal tract. An endoscopy-guided biopsy was done from the mass, which revealed signet ring cells (Fig. 3). A final diagnosis of gastric signet ring cell carcinoma with bone marrow metastasis was rendered. The patient was referred to a paediatric oncology clinic to begin chemotherapy with epirubicin, oxaliplatin, and capecitabine. Unfortunately, after only one cycle of chemotherapy, the patient died of his condition.
Discussion
In 2020, gastric cancer ranked as the fifth most prevalent form of cancer and the fourth highest contributor to cancer-related deaths globally. In 2020, about one million gastric cancer cases were expected, with significant geographic variance. East Asian and Eastern European regions have the highest male and female incidence rates, while two-thirds of cases worldwide are male. Mortality and incidence are significantly associated, indicating poor survival and emphasising the need for early diagnosis [7–9].
The incidence of gastric cancer has declined due to alterations in specific environmental and socioeconomic factors. The primary factors contributing to the lower occurrence is decreased Helicobacter pylori infection and reduced consumption of salted fish and meats, as well as reduced intake of smoked foods. In contrast, over the past 30 years, there has been an increase in the diffuse form of stomach cancer, but the cause is unknown [10, 11].
Gastric cancer has been classified into 2 forms, namely intestinal-type and diffuse-type [12]. Diffuse- type gastric cancer is characterised by its tendency to occur at a younger age and to be more advanced at the time of diagnosis, in comparison to well differentiated or moderately differentiated intestinal-type gastric cancer [13]. Hereditary illnesses such as hereditary diffuse gastric cancer (HDGC) have been highlighted in studies as traditional risk factors for gastric carcinoma in children. The most common gene involved in HDGC is CDH1. A CDH1 gene mutation increases the risk of gastric cancer and other HDGC-related malignancies [14]. This is especially important in the present case because this patient was a young child who presented with gastric signet ring cell adenocarcinoma; however, the mutation analysis for CDH1 yielded negative results. Our patient presented at a younger age with an advanced stage at the time of diagnosis, which is a characteristic of diffuse-type gastric adenocarcinoma.
The present case study is remarkable in that it solely complained of back discomfort, lower-limb weakness, and loss of urine and bowel continence, denying any gastrointestinal bleeding complaints. Our patient was eventually identified with signet ring cell gastric adenocarcinoma after a thorough clinical examination along with the integration of imaging, histology, and immunohistochemistry studies.
Bone marrow metastases in gastric cancer have been documented; however, they are very rare at the time of diagnosis. The identification of bone marrow involvement is often made during the workup for metastatic disease [4]. A peripheral blood smear examination of the patient in this case study revealed anaemia and leucoerythroblastic blood picture, both of which were linked with bone marrow metastases in a few previous studies [5–7]. Bone marrow metastasis is more prevalent in gastric cancer patients with the signet ring cell subtype and younger age of presentation. Patients with gastric adenocarcinoma have a dismal prognosis following bone marrow involvement; their average survival time is 44 days from the time of bone marrow metastasis detection [15]. The patient in the current case succumbed to his illness 28 days after being diagnosed with metastatic marrow disease. Chemotherapy improves survival rates compared to the best supportive care for advanced gastric cancer. Bone marrow metastases in gastric cancer patients are extremely rare; thus, their clinicopathological characteristics along with treatment choices are still being determined. Patients have a catastrophic prognosis with short survival times.
Conclusions
In a young child with an abdominal mass and lower back pain, primarily a broad differential diagnosis is first emphasised. Secondly, diffuse-type gastric cancer patients, especially younger ones, may have bone marrow involvement. A signet ring morphology on bone marrow examination in a younger patient may indicate signet ring gastric carcinoma with marrow metastases.
Disclosures
1. Institutional review board statement: Not applicable.
2. Assistance with the article: None.
3. Financial support and sponsorship: None.
4. Conflicts of interest: None.
References
1. Zahnreich S, Schmidberger H. Childhood cancer: occurrence, treatment and risk of second primary malignancies. Cancers (Basel) 2021; 13: 2607.
2.
Lin CH, Lin WC, Lai IH, Wu SF, Wu KH, Chen AC. Pediatric gastric cancer presenting with massive ascites. World J Gastroenterol 2015; 21: 3409-3413.
3.
Luo Z, Rong Z, Huang C. Surgery strategies for gastric cancer with liver metastasis. Front Oncol 2019; 9: 1353.
4.
Ekinci AŞ, Bal O, Ozatlı T. Gastric carcinoma with bone marrow metastasis: a case series. J Gastric Cancer 2014; 14: 54-57.
5.
Singh A, Rawat S, Yadav G, Kushwaha R, Verma SP, Singh US. Study of hemato-morphological features in neuroblastoma infiltrating marrow. J Lab Physicians 2022; 15: 224-229.
6.
Yadav G, Singh A, Kushwaha R, Verma N, Srivastava RM, Singh US. Utility of bone marrow examination in retinoblastoma and their correlation with hematological features. J Med Life 2023; 16: 1245-1250.
7.
Morgan E, Arnold M, Camargo MC, et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study. EClinicalMedicine 2022; 47: 101404.
8.
Arnold M, Abnet CC, Neale RE. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology 2020; 159: 335-349.
9.
Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol 2019; 14: 26-38.
10.
Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol 2022; 28: 1187-1203.
11.
Fuccio L, Eusebi LH, Bazzoli F. Gastric cancer, Helicobacter pylori infection and other risk factors. World J Gastrointest Oncol 2010; 2: 342-347.
12.
Iyer P, Moslim M, Farma JM, Denlinger CS. Diffuse gastric cancer: histologic, molecular, and genetic basis of disease. Transl Gastroenterol Hepatol 2020; 5: 52.
13.
Hu B, El Hajj N, Sittler S, Lammert N, Barnes R, Meloni-Ehrig A. Gastric cancer: classification, histology and application of molecular pathology. J Gastrointest Oncol 2012; 3: 251-261.
14.
Blair VR, McLeod M, Carneiro F, et al. Hereditary diffuse gastric cancer: updated clinical practice guidelines. Lancet Oncol 2020; 21: 386-397.
15.
Dittus C, Mathew H, Malek A, Negroiu A. Bone marrow infiltration as the initial presentation of gastric signet ring cell adenocarcinoma. J Gastrointest Oncol 2014; 5: 113-116.